- Preventive Mastectomy Rates Vary by State
- Many Women Who Get Breast Cancer Gene Test Don’t Need It
- High Doses of Vitamin D Fail to Cut Cancer Risk, Study Finds
- Is MRI the ‘Mammography’ of Prostate Cancer Screening?
- TV Ads for ACA Enrollment Linked to Decline in Uninsured Rates
- ACP Issues Challenge to Cut Task Burden and Put Patients First
- Psoriasis May Up Risk of Melanoma, Hematologic Cancer
Bert Vogelstein MD. Investigators at Johns Hopkins University in Baltimore used complex mathematical modeling to track mutations driving abnormal cell growth for 32 types of cancer. From their calculations, the researchers believe that the bulk of cancers are caused by random DNA copying errors (replicative mutations).… Dr. A. De la Guerra. The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
M. Aroon Kamath, M.D..
For a non-hematologist like me, what was striking at the very outset while beginning to learn about cell counting, was the remarkable way in which techniques of cell counting (hematology) and particle counting (physics) have complemented and contributed to each other. It is indeed interesting…
Thank you for reading my article. Interesting theory. Lots of research is ongoing to figure out the many ways aspirin does it magic.
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.